Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of recombinant human Lp-PLA2 using 2-thio-PAF as substrate preincubated for 30 mins followed by substrate addition
Assay data:1 Active, 1 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of PLA2G7 in human intact PC3 cells preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assay
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of PLA2G7 derived from human PC3 cell lysates preincubated for 30 mins followed by JW912 addition after 30 mins by gel-based ABPP assay
Assay data:24 Active, 16 Activity ≤ 1 µM, 33 Tested
Inhibition of human PLA2G7 at 10 uM relative to control
Inhibition of human PLA2G7 at 1 to 10 uM relative to control
Inhibition of human recombinant GST-tagged Lp-PLA2 (47 to 429 residues) expressed in Escherichia coli Rosetta(DE3) pLysS at 1000 uM using 2-thio-PAF as substrate preincubated for 30 min followed by substrate addition measured every minute for 10 mins relative to control
Inhibition of Lp-PLA2 in human plasma at 50 nM using 2-thio-PAF as substrate preincubated for 30 min followed by substrate addition measured every minute for 10 mins by DNTB reagent based assay relative to control
Assay data:11 Tested
Inhibition of human recombinant GST-tagged Lp-PLA2 (47 to 429 residues) expressed in Escherichia coli Rosetta(DE3) pLysS using 2-thio-PAF as substrate preincubated for 30 min followed by substrate addition measured every minute for 10 mins by DNTB reagent based assay
Assay data:29 Active, 1 Activity ≤ 1 nM, 23 Activity ≤ 1 µM, 30 Tested
Inhibition of human recombinant GST-tagged Lp-PLA2 (47 to 429 residues) expressed in Escherichia coli Rosetta(DE3) pLysS at 2.5 uM using 2-thio-PAF as substrate preincubated for 30 min followed by substrate addition measured every minute for 10 mins by DNTB reagent based assay relative to control
Assay data:10 Tested
Inhibition of human recombinant GST-tagged Lp-PLA2 (47 to 429 residues) expressed in Escherichia coli Rosetta(DE3) pLysS at 25 uM using 2-thio-PAF as substrate preincubated for 30 min followed by substrate addition measured every minute for 10 mins by DNTB reagent based assay relative to control
Assay data:19 Tested
Inhibition of Lp-PLA2 in human plasma at 250 nM using 2-thio-PAF as substrate preincubated for 30 min followed by substrate addition measured every minute for 10 mins by DNTB reagent based assay relative to control
Inhibition of human Lp-PLA2
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Inhibition of Lp-PLA2 in human plasma LDL fractions using 2-thio platelet-activating factor as substrate by TMB dye based spectrophotometry
Assay data:2 Active, 1 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 4 Tested
Inhibition of Lp-PLA2 in human plasma LDL fractions assessed as residual enzyme activity at 0.1 nM using 2-thio platelet-activating factor as substrate by TMB dye based spectrophotometry
Assay data:4 Tested
Inhibition of Lp-PLA2 in human plasma LDL fractions assessed as residual enzyme activity at 1 nM using 2-thio platelet-activating factor as substrate by TMB dye based spectrophotometry
Inhibition of Lp-PLA2 in human plasma LDL fractions assessed as residual enzyme activity at 10 nM using 2-thio platelet-activating factor as substrate by TMB dye based spectrophotometry
Inhibition of Lp-PLA2 in human plasma LDL fractions assessed as residual enzyme activity at 100 nM using 2-thio platelet-activating factor as substrate by TMB dye based spectrophotometry
Inhibition of Lp-PLA2 in human plasma LDL fractions assessed as residual enzyme activity at 500 nM using 2-thio platelet-activating factor as substrate by TMB dye based spectrophotometry
Inhibition of Lp-PLA2 in human plasma LDL fractions assessed as residual enzyme activity at 1000 nM using 2-thio platelet-activating factor as substrate by TMB dye based spectrophotometry
Human PLA2-G7 (Hydrolases)
Assay data:4 Active, 4 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on